CY1107603T1 - Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης - Google Patents

Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης

Info

Publication number
CY1107603T1
CY1107603T1 CY20071100021T CY071100021T CY1107603T1 CY 1107603 T1 CY1107603 T1 CY 1107603T1 CY 20071100021 T CY20071100021 T CY 20071100021T CY 071100021 T CY071100021 T CY 071100021T CY 1107603 T1 CY1107603 T1 CY 1107603T1
Authority
CY
Cyprus
Prior art keywords
hematopoietic
growth hormone
thepapeies
myelovlastikes
epanametangisis
Prior art date
Application number
CY20071100021T
Other languages
English (en)
Inventor
Alessandro Massimo Gianni
Original Assignee
Laboratoires Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serono Sa filed Critical Laboratoires Serono Sa
Publication of CY1107603T1 publication Critical patent/CY1107603T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Η εφεύρεση αφορά το πεδίο της κινητοποίησης των αιματοποιητικών κυττάρων CD34+. Πιο συγκεκριμένα, η εφεύρεση αυτή αφορά μια μέθοδο για την αύξηση της κινητοποίησης των πολυδυναμικών αιματοποιητικών κυττάρων CD34+ με τη χορήγηση της ανθρώπινης ορμόνης ανάπτυξης ή ενός εκ των παραγώγων της στο άτομο.
CY20071100021T 1998-12-30 2007-01-08 Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης CY1107603T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
EP99965579A EP1140149B1 (en) 1998-12-30 1999-12-30 Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment

Publications (1)

Publication Number Publication Date
CY1107603T1 true CY1107603T1 (el) 2013-03-13

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100021T CY1107603T1 (el) 1998-12-30 2007-01-08 Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης

Country Status (15)

Country Link
US (1) US20060029581A1 (el)
EP (3) EP1016413A1 (el)
JP (1) JP4808316B2 (el)
AT (1) ATE342064T1 (el)
AU (2) AU772222B2 (el)
BR (1) BR9916726A (el)
CA (1) CA2354194A1 (el)
CY (1) CY1107603T1 (el)
DE (1) DE69933581T2 (el)
DK (1) DK1140149T3 (el)
ES (1) ES2275359T3 (el)
IL (2) IL143994A0 (el)
PT (1) PT1140149E (el)
SI (1) SI1140149T1 (el)
WO (1) WO2000040260A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040028649A1 (en) * 2000-06-07 2004-02-12 GIANNI Alessandro Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
AU8617301A (en) 2000-08-01 2002-02-13 Yissum Res Dev Co Directed differentiation of embryonic cells
AU2002318927B2 (en) * 2001-07-31 2007-01-04 Genzyme Corporation Methods to mobilize progenitor/stem cells
WO2005032572A2 (en) * 2003-10-03 2005-04-14 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
US7816320B2 (en) * 2004-12-22 2010-10-19 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
CN104017063A (zh) * 2009-12-21 2014-09-03 Ambrx公司 经过修饰的猪促生长素多肽和其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
EP0703784B1 (en) * 1993-06-15 2002-03-06 British Biotech Pharmaceuticals Limited Release and mobilisation of haematopoietic cells
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
IL111181A0 (en) * 1993-10-06 1994-12-29 Univ Florida Stem cell proliferation factor, its preparation, purification and uses
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
CA2227241C (en) * 1995-07-21 2004-12-21 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
ES2226326T3 (es) * 1998-12-17 2005-03-16 Applied Research Systems Ars Holding N.V. Hormona de crecimiento humana para estimular la hematopoyesis y la reconstitucion del sistema inmune despues del trasplante de celulas madre hematopoyeticas en seres humanos.
US20040028649A1 (en) * 2000-06-07 2004-02-12 GIANNI Alessandro Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
JP4808316B2 (ja) 2011-11-02
EP1140149A1 (en) 2001-10-10
IL143994A0 (en) 2002-04-21
CA2354194A1 (en) 2000-07-13
EP1016413A1 (en) 2000-07-05
EP1140149B1 (en) 2006-10-11
ATE342064T1 (de) 2006-11-15
US20060029581A1 (en) 2006-02-09
IL143994A (en) 2009-06-15
DE69933581D1 (de) 2006-11-23
DE69933581T2 (de) 2007-06-21
AU2004203355B2 (en) 2007-05-17
WO2000040260A1 (en) 2000-07-13
AU2004203355A1 (en) 2004-08-19
PT1140149E (pt) 2007-01-31
DK1140149T3 (da) 2007-02-19
AU772222B2 (en) 2004-04-22
ES2275359T3 (es) 2007-06-01
JP2002534393A (ja) 2002-10-15
AU2103900A (en) 2000-07-24
SI1140149T1 (sl) 2007-02-28
BR9916726A (pt) 2001-09-11
EP1779865A1 (en) 2007-05-02

Similar Documents

Publication Publication Date Title
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
ATE286118T1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
CY1107778T1 (el) Ανθρωπινα cd45+ ή/και ινοβλαστης + μεσεγχυματικα βλαστικα κυτταρα
TR200001228T2 (tr) T yardımcı hücre tür 2 kökenli bağışıklık hastalıklarının retinoit antagonistlerle tedavisi
MY113488A (en) Compounds with growth hormone releasing properties
ATE199096T1 (de) Il-11 aus säugetier
DK240088A (da) Fremgangsmaade til transformation af et plantecellematerale
MX9305150A (es) Filtro activo para reducir voltajes y corrientes no basicos.
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
DE69630955D1 (de) Immortalisierung bzw. desimmortalisierung von zellen
FR2662698B1 (el)
ATE514771T1 (de) Haartransplantation
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
IT8120393A0 (it) Mutanti batterici, procedimento per produrli e vaccini vivi che licontengono.
FR2749022B1 (fr) Cellules aviaires immortelles
ATE226087T1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
AU4751797A (en) Defined systems for epithelial cell culture and use thereof
ES2002915A6 (es) Un procedimiento para la preparacion de un peptido de veneno de serpiente que detiene el crecimiento.
PT765398E (pt) Populacao de celulas enriquecedoras em progenitores mieloides e linfoides e metodos de as fazer e utilizar
DK0793503T3 (da) Anvendelse af hepatocyt-vækstfaktor til inducering af profilerering og differentiering af hemotopoietiske celler
ATE278461T1 (de) Mikropartikel hergestellt aus cycloolefincopolymeren und deren verwendung zur kontrollierten wirkstofffreigabe
EP0925064A4 (en) 5-ANDROSTEN 3-beta, 17-alpha DIOL AS A TUMOR GROWTH INHIBITOR
PT1016414E (pt) Hormona de crescimento humano para estimular a hematopoiese e a reconstituicao imnologica apos transplante de celulas estaminais hematopoieticas em humanos